The use and misuse of risk prediction tools for clinical decision-making.
作者信息
van Maaren Marissa C, Hueting Tom A, Völkel Vinzenz, van Hezewijk Marjan, Strobbe Luc Ja, Siesling Sabine
机构信息
Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Evidencio Medical Decision Support, Haaksbergen, the Netherlands.
出版信息
Breast. 2023 Jun;69:428-430. doi: 10.1016/j.breast.2023.01.006. Epub 2023 Jan 21.
Abstract
摘要
相似文献
1
The use and misuse of risk prediction tools for clinical decision-making.用于临床决策的风险预测工具的使用与误用。
Breast. 2023 Jun;69:428-430. doi: 10.1016/j.breast.2023.01.006. Epub 2023 Jan 21.
2
Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting.高危女性和初级保健环境中的医疗保健提供者的乳腺癌化学预防决策支持工具的初步研究。
BMC Med Inform Decis Mak. 2018 Dec 17;18(1):134. doi: 10.1186/s12911-018-0716-5.
3
Making the breast multidisciplinary team meeting relevant again.让乳腺多学科团队会议再次发挥作用。
Breast J. 2020 Sep;26(9):1915-1916. doi: 10.1111/tbj.13837. Epub 2020 Apr 11.
4
Key Elements of Mammography Shared Decision-Making: a Scoping Review of the Literature.乳腺 X 线摄影共享决策的关键要素：文献的范围综述。
J Gen Intern Med. 2018 Oct;33(10):1805-1814. doi: 10.1007/s11606-018-4576-6. Epub 2018 Jul 20.
5
The availability and effectiveness of tools supporting shared decision making in metastatic breast cancer care: a review.支持转移性乳腺癌护理中共同决策的工具的可用性和有效性：综述。
BMC Palliat Care. 2018 May 11;17(1):74. doi: 10.1186/s12904-018-0330-4.
6
Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.将临床病理和基因组工具整合到早期乳腺癌化疗决策中。
Future Oncol. 2017 Dec;13(28):2507-2510. doi: 10.2217/fon-2017-0452. Epub 2017 Nov 23.
7
Use of an Online Breast Cancer Risk Assessment and Patient Decision Aid in Primary Care Practices.在线乳腺癌风险评估和患者决策辅助工具在初级保健实践中的应用。
J Womens Health (Larchmt). 2020 Jun;29(6):763-769. doi: 10.1089/jwh.2019.8143. Epub 2020 Mar 10.
8
Communicating prognosis to women with early breast cancer - overview of prediction tools and the development and pilot testing of a decision aid.向早期乳腺癌女性传达预后信息——预测工具概述及决策辅助工具的开发与初步测试
BMC Health Serv Res. 2019 Mar 15;19(1):171. doi: 10.1186/s12913-019-3988-2.
9
The role of comorbidity assessment in guiding treatment decision-making for women with early breast cancer: a systematic literature review.合并症评估在指导早期乳腺癌女性治疗决策中的作用：系统文献回顾。
Support Care Cancer. 2020 Mar;28(3):1041-1050. doi: 10.1007/s00520-019-05218-w. Epub 2019 Dec 11.
10
When Is Using a Prediction Model Better Than No Model to Inform Clinical Decision Making?在何种情况下，使用预测模型比不使用模型来指导临床决策更好？
J Urol. 2022 Sep;208(3):530-533. doi: 10.1097/JU.0000000000002833. Epub 2022 Jun 24.
引用本文的文献
1
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?与经典临床病理评分（PREDICT 2.1、INFLUENCE 2.0、CTS5）相比，RSClin是否能提供更多信息？
Breast. 2025 Jul 4;83:104528. doi: 10.1016/j.breast.2025.104528.
2
Bridging the Gap: A Mixed-Methods Study on Factors Influencing Breast Cancer Clinicians' Decisions to Use Clinical Prediction Models.弥合差距：一项关于影响乳腺癌临床医生使用临床预测模型决策因素的混合方法研究
MDM Policy Pract. 2025 Mar 27;10(1):23814683251328377. doi: 10.1177/23814683251328377. eCollection 2025 Jan-Jun.
3
Emergency department early mortality model for patients admitted after presenting to a tertiary medical center emergency department.三级医疗中心急诊科就诊后入院患者的急诊科早期死亡模型
Acad Emerg Med. 2025 Jun;32(6):650-658. doi: 10.1111/acem.15096. Epub 2025 Jan 16.
4
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.INFLUENCE 3.0模型：局部区域复发和对侧乳腺癌的更新预测，现在也适用于接受新辅助全身治疗的患者。
Breast. 2025 Feb;79:103829. doi: 10.1016/j.breast.2024.103829. Epub 2024 Oct 28.
5
Relationship between spinal alignment and functional disability after thoracolumbar spinal fractures: A systematic review.胸腰椎骨折后脊柱排列与功能障碍之间的关系：一项系统评价。
N Am Spine Soc J. 2024 Jul 18;19:100529. doi: 10.1016/j.xnsj.2024.100529. eCollection 2024 Sep.
本文引用的文献
1
Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study.荷兰基于人群的研究：PORTRET 工具的开发和验证，用于预测老年乳腺癌患者的复发、总生存和其他原因死亡率。
Lancet Healthy Longev. 2021 Nov;2(11):e704-e711. doi: 10.1016/S2666-7568(21)00229-4. Epub 2021 Nov 3.
2
Incorporating progesterone receptor expression into the PREDICT breast prognostic model.将孕激素受体表达纳入 PREDICT 乳腺癌预后模型。
Eur J Cancer. 2022 Sep;173:178-193. doi: 10.1016/j.ejca.2022.06.011. Epub 2022 Aug 4.
3
A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer.交互式和个性化的基于网络的临床工具在乳腺癌治疗决策支持中的应用：范围综述。
Breast. 2022 Feb;61:43-57. doi: 10.1016/j.breast.2021.12.003. Epub 2021 Dec 6.
4
Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.改良早期乳腺癌局部区域复发、对侧第二原发肿瘤和远处转移的风险评估：INFLUENCE 2.0 模型。
Breast Cancer Res Treat. 2021 Oct;189(3):817-826. doi: 10.1007/s10549-021-06335-z. Epub 2021 Aug 2.
5
TRIPOD Reporting Guidelines for Diagnostic and Prognostic Studies.诊断和预后研究的TRIPOD报告指南。
JAMA Surg. 2021 Jul 1;156(7):675-676. doi: 10.1001/jamasurg.2021.0537.
6
Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.评估未测量混杂因素对可信可靠真实世界证据的影响。
Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1219-1227. doi: 10.1002/pds.5117. Epub 2020 Sep 14.
7
Prediction meets causal inference: the role of treatment in clinical prediction models.预测与因果推断：治疗在临床预测模型中的作用。
Eur J Epidemiol. 2020 Jul;35(7):619-630. doi: 10.1007/s10654-020-00636-1. Epub 2020 May 22.
8
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.PROBAST：一种用于评估偏倚风险和预测模型研究适用性的工具。
Ann Intern Med. 2019 Jan 1;170(1):51-58. doi: 10.7326/M18-1376.
9
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.一种经过更新且具有独立验证的PREDICT乳腺癌预后及治疗获益预测模型。
Breast Cancer Res. 2017 May 22;19(1):58. doi: 10.1186/s13058-017-0852-3.
10
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.透明报告个体预后或诊断的多变量预测模型（TRIPOD）：解释和说明。
Ann Intern Med. 2015 Jan 6;162(1):W1-73. doi: 10.7326/M14-0698.
Zotero 插件